Tel Aviv / Zurich, 31 May 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that Elon Shalev, member of the Board of Directors, has stepped down from his duties effective 30 May 2021. SHL’s Board of Directors appointed David Salton as independent, non-executive director effective as of 31 May 2021.
For more information Click here
